Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
106536363 | 10653636 | 3 | F | 20160912 | 20141216 | 20160916 | EXP | FR-009507513-0906FRA00102 | MERCK | 0.00 | M | Y | 0.00000 | 20160916 | CN | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
106536363 | 10653636 | 1 | PS | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | 100 MG, QD | Y | 21995 | 100 | MG | FILM-COATED TABLET | QD | |||||
106536363 | 10653636 | 2 | C | ATENOLOL. | ATENOLOL | 1 | Oral | U | 0 | TABLET | |||||||||
106536363 | 10653636 | 3 | C | RAMIPRIL. | RAMIPRIL | 1 | Oral | U | 0 | TABLET | |||||||||
106536363 | 10653636 | 4 | C | PRAVASTATIN SODIUM. | PRAVASTATIN SODIUM | 1 | Oral | 20 MG, QD | U | 0 | 20 | MG | TABLET | QD | |||||
106536363 | 10653636 | 5 | C | ASPIRIN LYSINE | ASPIRIN LYSINE | 1 | Oral | U | 0 | POWDER | |||||||||
106536363 | 10653636 | 6 | C | PANTOPRAZOLE SODIUM. | PANTOPRAZOLE SODIUM | 1 | Oral | U | 0 | ||||||||||
106536363 | 10653636 | 7 | C | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | Oral | U | 0 | TABLET | |||||||||
106536363 | 10653636 | 8 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | U | 0 | TABLET | |||||||||
106536363 | 10653636 | 9 | C | GLYBURIDE. | GLYBURIDE | 1 | Oral | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
106536363 | 10653636 | 1 | Type 2 diabetes mellitus |
106536363 | 10653636 | 2 | Type 2 diabetes mellitus |
106536363 | 10653636 | 3 | Hypertension |
106536363 | 10653636 | 4 | Dyslipidaemia |
106536363 | 10653636 | 7 | Autoimmune thyroiditis |
106536363 | 10653636 | 8 | Type 2 diabetes mellitus |
106536363 | 10653636 | 9 | Type 2 diabetes mellitus |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
106536363 | 10653636 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
106536363 | 10653636 | Pemphigoid |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
106536363 | 10653636 | 1 | 200810 | 200901 | 0 |